Top

Obesity Surgery

Published in:

10-01-2024 | Bariatric Surgery | Letter to the Editor

GLP-1 Receptor Agonists in Weight Loss and Bariatric Surgery: Balancing Efficacy and Gastrointestinal Adverse Events

Authors: Kahei Au, Wah Yang

Published in: Obesity Surgery | Issue 4/2024

Excerpt

To the Editor, …

Han SH, Safeek R, Ockerman K, et al. Public Interest in the off-label use of glucagon-like peptide 1 agonists (Ozempic) for cosmetic weight loss: a google trends analysis. Aesthet Surg J. 2023;sjad211. https://doi.org/10.1093/asj/sjad211.

Sodhi M, Rezaeianzadeh R, Kezouh A, et al. Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss. JAMA. 2023; e2319574. https://doi.org/10.1001/jama.2023.19574.

Liu L, Chen J, Wang L, et al. Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: a real-world disproportionality study based on FDA adverse event reporting system database. Front Endocrinol (Lausanne). 2022;7(13):1043789. https://doi.org/10.3389/fendo.2022.1043789.CrossRef

Gorgojo-Martínez JJ, Mezquita-Raya P, Carretero-Gómez J, et al. Clinical recommendations to manage gastrointestinal adverse events in patients treated with Glp-1 receptor agonists: a multidisciplinary expert consensus. J Clin Med. 2022;12(1):145. https://doi.org/10.3390/jcm12010145.CrossRefPubMedPubMedCentral

Borner T, Shaulson ED, Tinsley IC, et al. A second-generation glucagon-like peptide-1 receptor agonist mitigates vomiting and anorexia while retaining glucoregulatory potency in lean diabetic and emetic mammalian models. Diabetes Obes Metab. 2020;22(10):1729–41. https://doi.org/10.1111/dom.14089.CrossRefPubMedPubMedCentral

Title: GLP-1 Receptor Agonists in Weight Loss and Bariatric Surgery: Balancing Efficacy and Gastrointestinal Adverse Events
Authors: Kahei Au
Wah Yang
Publication date: 10-01-2024
Publisher: Springer US
Keywords: Bariatric Surgery
Bariatric Surgery
Incretin Mimetics
Incretin Mimetics
Published in: Obesity Surgery / Issue 4/2024
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-024-07061-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

GLP-1 Receptor Agonists in Weight Loss and Bariatric Surgery: Balancing Efficacy and Gastrointestinal Adverse Events

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2024

Smoking Is Correlated to Internal Hernia After Gastric Bypass Surgery: a Post hoc Analysis of Data from a Randomized Clinical Trial

Transferrin Saturation, Serum Ferritin, and C-Reactive Protein vs. Serum Ferritin for an optimal Iron Deficiency Diagnosis in Candidates for Bariatric Surgery

Convincing 10-Year Follow-up Results of the Banded Roux-en-Y Gastric Bypass

A Simple Way to Estimate a Difficult Sleeve Gastrectomy Prior to Operating

The Controversy Surrounding Botulinum Neurotoxin (BONT) as a Weight Loss Intervention in Turkish Healthcare Realities

Impact of Bariatric Surgery on Circulating Metabolites and Cognitive Performance